Details for New Drug Application (NDA): 018300
✉ Email this page to a colleague
NDA 018300 describes HIBISTAT, which is a drug marketed by Molnlycke Hlth and is included in one NDA. Additional details are available on the HIBISTAT profile page.
The generic ingredient in HIBISTAT is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
The generic ingredient in HIBISTAT is chlorhexidine gluconate. There are fifty-eight drug master file entries for this compound. Fifty-seven suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.
Summary for 018300
| Tradename: | HIBISTAT |
| Applicant: | Molnlycke Hlth |
| Ingredient: | chlorhexidine gluconate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018300
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | SOLUTION;TOPICAL | Strength | 0.5% | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
